Status:

COMPLETED

Peri-implant Phenotype, Calprotectin and Mmp-8 Levels in Cases Diagnosed With Peri-implant Disease

Lead Sponsor:

Beliz Önder

Conditions:

Peri-implant Mucositis

Peri-Implantitis

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

Following the implantation procedures; The peri-implant mucosa may begin to show signs of inflammation depending on the patient (bruxism, lack of oral hygiene) or other factors (planning errors, iatro...

Detailed Description

The study was carried out in Van Yüzüncü Yıl University Faculty of Dentistry, in patients who were diagnosed with inflammation or bone loss around their implants and were referred to Periodontology De...

Eligibility Criteria

Inclusion

  • -Systemically healthy,
  • Non-smoker,
  • There is no drug allergy and no advanced surgical techniques are required.
  • 39 volunteers, aged 18-65, who applied to the Department of Periodontics with complaints of infection around the implant or were referred to our clinic, will be included.

Exclusion

  • Any drug allergy,
  • Pregnant or breastfeeding,
  • smoker
  • Having a systemic disability,
  • Peri-implant disease requiring advanced surgical techniques for treatment
  • Individuals who are not volunteers

Key Trial Info

Start Date :

August 21 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 22 2022

Estimated Enrollment :

39 Patients enrolled

Trial Details

Trial ID

NCT06173739

Start Date

August 21 2020

End Date

March 22 2022

Last Update

December 18 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Van Yüzüncü Yıl Unıversity

Van, Turkey (Türkiye), 65080

Peri-implant Phenotype, Calprotectin and Mmp-8 Levels in Cases Diagnosed With Peri-implant Disease | DecenTrialz